Stockscreener 앱 받기
12.04
0.55%
0.115
전일 마감가:
$11.92
열려 있는:
$11.96
하루 거래량:
34,907
Relative Volume:
0.10
시가총액:
$771.81M
수익:
-
순이익/손실:
-
주가수익비율:
-11.96
EPS:
-1.0062
순현금흐름:
-
1주 성능:
+12.01%
1개월 성능:
-19.02%
6개월 성능:
+768.48%
1년 성능:
+547.84%
1일 변동 폭
$11.80
$12.69
1주일 범위
$10.50
$12.69
52주 변동 폭
$0.8786
$17.25
Adlai Nortye Ltd Adr Stock (ANL) Company Profile
Compare ANL vs VRTX, REGN, ARGX, ALNY, RVMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ANL
Adlai Nortye Ltd Adr
|
11.98 | 767.62M | 0 | 0 | 0 | -1.0062 |
VRTX
Vertex Pharmaceuticals Inc
|
436.42 | 110.28B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
635.16 | 66.98B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
811.00 | 50.15B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
296.44 | 39.71B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
153.87 | 32.22B | 742.00K | -1.37B | -1.07B | -7.0731 |
Adlai Nortye Ltd Adr Stock (ANL) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-03-20 | 개시 | Leerink Partners | Outperform |
| 2026-02-13 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
| 2025-06-02 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2024-09-04 | 개시 | H.C. Wainwright | Buy |
| 2023-10-24 | 개시 | Cantor Fitzgerald | Overweight |
Adlai Nortye Ltd Adr 주식(ANL)의 최신 뉴스
Adlai Nortye CEO Lu Yang sells $131 in company stock By Investing.com - Investing.com Canada
Adlai Nortye CEO Lu Yang sells $131 in company stock - Investing.com
Adlai Nortye initiated with a Buy at JonesResearch - TipRanks
Adlai Nortye Ltd. Sponsored ADR (ANL) Upgraded to Buy: Here's What You Should Know - Yahoo Finance
Analysts Are Bullish on These Healthcare Stocks: Aquestive Therapeutics (AQST), Monopar Therapeutics Inc (MNPR) - The Globe and Mail
Analysts Offer Insights on Healthcare Companies: Kairos Pharma, Ltd. (KAPA), Integra Lifesciences (IART) and Biogen (BIIB) - The Globe and Mail
Are Medical Stocks Lagging ABCELLERA BIOLG (ABCL) This Year? - Yahoo Finance
Here's why Adlai Nortye Ltd. sponsored ADR (ANL) is a great 'buy the bottom' stock now - MSN
Here's Why Adlai Nortye Ltd. Sponsored ADR (ANL) Is a Great 'Buy the Bottom' Stock Now - Yahoo! Finance Canada
H.C. Wainwright Sees “Potential Best-in-Class Potency” for Adlai Nortye’s (ANL) Lead Asset, Lifts PT - Yahoo Finance
Adlai Nortye (NASDAQ:ANL) Trading 12.3% HigherHere's Why - MarketBeat
Adlai Nortye (ANL): 10 Tiny Stocks That Are On Fire Right Now - Yahoo Finance
Is ANI Pharmaceuticals (ANIP) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance
Adlai Nortye Ltd. Sponsored ADR (NASDAQ:ANL) Short Interest Update - MarketBeat
Is Adlai (ANL) stock a strong investment pick (Volatility Increases) 2026-04-27Crowd Signals - newser.com
Adlai Nortye (NASDAQ: ANL) registers $600M shelf; 32.9M ADS resale - Stock Titan
Adlai Nortye (NASDAQ:ANL) Shares Gap DownTime to Sell? - MarketBeat
Adlai Nortye FY2026 EPS Forecast Raised by HC Wainwright - MarketBeat
Adlai Nortye (NASDAQ:ANL) Sets New 1-Year HighStill a Buy? - MarketBeat
Adlai Nortye price target raised to $20 from $16 at H.C. Wainwright - TipRanks
Adlai (ANL) Stock Rallies on Launch (Smart Money Exits) 2026-04-20Most Discussed Stocks - Newser
Adlai Nortye (NASDAQ:ANL) Stock Price Up 18.1%What's Next? - MarketBeat
Adlai Nortye raises $150M in oversubscribed private placement By Investing.com - Investing.com India
Adlai Nortye Announces $150.0 Million Private Placement Equity Financing - Sahm
Adlai Nortye Raises $150 Million in Oversubscribed Private Placement to Advance Cancer Pipeline - TipRanks
Adlai Nortye (NASDAQ:ANL) Shares Gap UpShould You Buy? - MarketBeat
Adlai Nortye raises $150M in oversubscribed private placement - Investing.com
TeraWulf, BRP And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - Sahm
Adlai Nortye (NASDAQ:ANL) Trading Down 11.7%Here's What Happened - MarketBeat
Adlai Nortye (NASDAQ:ANL) Reaches New 52-Week HighShould You Buy? - MarketBeat
Day's Trending USA Stocks | AVNS: Overnight gain 69.5%, Surges on All-Cash Acquisition Deal by American Industrial Partners - Sahm
Adlai Nortye (ANL) Loss Narrows To US$18.3 Million Challenging Bearish Cash Burn Narrative - Sahm
FGI Industries, Nouveau Monde Graphite And Other Big Stocks Moving Lower In Friday's Pre-Market Session - Sahm
Is Astellas Pharma (ALPMY) Stock Outpacing Its Medical Peers This Year? - qz.com
Adlai Nortye Reshapes Top Leadership as President Retires and R&D Chief Steps Up - The Globe and Mail
Is Adlai Nortye Ltd. sponsored ADR (ANL) outperforming other medical stocks this year? - MSN
Adlai Nortye Ltd. sponsored ADR (ANL) upgraded to buy: Here's why - MSN
Adlai Nortye Ltd. Sponsored ADR (ANL) Raised to Buy: The Reason Behind This Change - Bitget
Adlai Nortye Ltd. Sponsored ADR (ANL) Upgraded to Buy: Here's Why - Yahoo Finance
ETFs Investing in Adlai Nortye Ltd. Sponsored ADR Stocks - TradingView
Analysts Offer Insights on Consumer Goods Companies: Clene (CLNN) and Ollie’s Bargain Outlet Holding (OLLI) - The Globe and Mail
Adlai Nortye (NASDAQ: ANL) files $600M shelf; 21.5M ADSs resale - Stock Titan
Is Adlai Nortye Ltd. Sponsored ADR (ANL) Outperforming Other Medical Stocks This Year? - Yahoo Finance
Analysts Offer Insights on Healthcare Companies: PepGen Inc. (PEPG) and Compass Therapeutics (CMPX) - The Globe and Mail
Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail
Analysts Offer Insights on Healthcare Companies: Fractyl Health, Inc. (GUTS), Ionis Pharmaceuticals (IONS) and Axsome Therapeutics (AXSM) - The Globe and Mail
Analysts Offer Insights on Healthcare Companies: Iovance Biotherapeutics (IOVA) and Palvella Therapeutics (PVLA) - The Globe and Mail
Analysts Offer Insights on Healthcare Companies: PDS Biotechnology (PDSB), Integer Holdings (ITGR) and Tonix Pharma (TNXP) - The Globe and Mail
Has Adlai Nortye Ltd. Sponsored ADR (ANL) Outpaced Other Medical Stocks This Year? - Yahoo Finance
Adlai Nortye upgraded to Buy at H.C. Wainwright as AN9025 enters clinic - TipRanks
Adlai Nortye Ltd Adr (ANL) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.25%
0.46%
자본화:
|
볼륨(24시간):